NCT04187456 - A Study in Healthy Male Subjects to Understand How Savolitinib When Taken With Midazolam Behaves Inside the Body | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 27, 2019

Primary Completion Date

March 6, 2020

Study Completion Date

March 6, 2020

Conditions

Solid Tumors

Interventions

DRUG

Savolitinib

Single dose (together with midazolam) on Study Day 5 after a high fat, high calorie breakfast.

DRUG

Midazolam

Single dose (alone) on Study Day 1 and single dose (together with savolitinib) on Study Day 5, both after a high fat, high calorie breakfast.

Trial Locations (1)

Research Site, Baltimore